Business · 11/01/2011
FDA Opens Public Docket to Discuss Midodrine Hydrochloride Clinical Trials
The FDA is launching a public forum to gather input on clinical trials for midodrine hydrochloride, a medication used to treat symptomatic orthostatic hypotension, in order to verify and describe its clinical benefits.
Original source language: Federal Register — Health and Human ServicesOpen original release →